Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab.

MLA

Angelopoulou, Maria K., et al. “Outcome and Toxicity in Relapsed Hairy Cell Leukemia Patients Treated with Rituximab.” Leukemia & Lymphoma, vol. 49, no. 9, Sept. 2008, pp. 1817–20. EBSCOhost, https://doi.org/10.1080/10428190802163289.

APA

Angelopoulou, M. K., Pangalis, G. A., Sachanas, S., Kokoris, S. I., Anargyrou, K., Galani, Z., Kalpadakis, C., & Vassilakopoulos, T. P. (2008). Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab. Leukemia & Lymphoma, 49(9), 1817–1820. https://doi.org/10.1080/10428190802163289

Chicago

Angelopoulou, Maria K., Gerassimos A. Pangalis, Sotirios Sachanas, Styliani I. Kokoris, Konstantinos Anargyrou, Zaharoula Galani, Christina Kalpadakis, and Theodoros P. Vassilakopoulos. 2008. “Outcome and Toxicity in Relapsed Hairy Cell Leukemia Patients Treated with Rituximab.” Leukemia & Lymphoma 49 (9): 1817–20. doi:10.1080/10428190802163289.